Aidoc
Aidoc is an enterprise clinical AI company that provides the aiOS platform and CARE foundation model for medical imaging triage and care coordination across radiology, cardiology, neurovascular, and vascular workflows, deployed at nearly 2,000 hospitals and 150+ health systems in 19 countries.
- Company typePrivate
- Founded2016
- HeadquartersTel Aviv, Israel
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Aidoc does
Aidoc is a clinical artificial intelligence company founded in 2016 in Tel Aviv, Israel, that develops AI-powered software for healthcare imaging and clinical workflows. The company sells an enterprise SaaS platform — the aiOS Clinical AI Operating System — and a proprietary foundation model called CARE (Clinical AI Reasoning Engine), trained on multimodal data (imaging, clinical notes, lab results) via self-supervised learning. On top of these core technologies, Aidoc delivers specialty AI applications across radiology (largest FDA-cleared portfolio), cardiology (coronary artery disease, echocardiography), neurovascular (stroke, hemorrhage, aneurysm, spine), and vascular (PE, DVT, aortic disease, IVC filters), with add-on modules for care coordination and patient management. The platform also operates as a multi-vendor AI marketplace, with 69% of customers running non-Aidoc models on aiOS alongside native solutions.
The company distributes exclusively through enterprise direct sales to large health systems and hospital networks globally, employing a field sales motion with pilots that transition to enterprise-wide deployments under multi-year subscription contracts. Aidoc's platform is deployed at nearly 2,000 hospitals and more than 150 health systems across 19 countries, analyzing over 60 million patient cases annually (120 million+ cumulatively), with documented customers including Mercy, WellSpan Health, Mount Sinai, Hartford HealthCare, Northwell Health, Sutter Health, Houston Methodist, and Asklepios Group. The company has raised over $500 million in total funding — including a $150 million Series E in April 2026 led by Goldman Sachs Alternatives at a $5 billion post-money valuation — and is positioning for a potential IPO in 2026-2027. Aidoc holds 14 FDA-cleared acute indications (including the industry's first comprehensive foundation-model-powered triage clearance), two FDA Breakthrough Device Designations, CE marking, and compliance with MDSAP, ISO 13485, EU MDR, HIPAA, and GDPR.
Aidoc firmographics
Firmographics- Name
- Aidoc
- Legal name
- Aidoc Medical Ltd.
- Website
- https://aidoc.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Aidoc is an enterprise clinical AI company that provides the aiOS platform and CARE foundation model for medical imaging triage and care coordination across radiology, cardiology, neurovascular, and vascular workflows, deployed at nearly 2,000 hospitals and 150+ health systems in 19 countries.
- Ownership category
- akta.pro rank
Aidoc industry classification
Industry- Product category
- Clinical AI Software for Healthcare Imaging
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)
- akta.pro secondary industries
- AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)
Keywords
Where Aidoc is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices4 records
Markets served
Aidoc business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Clinical AI Platform Subscription: Aidoc operates on a subscription-based SaaS model targeting health systems and hospitals. The platform is deployed enterprise-wide across health systems with annual or multi-year contracts. Revenue is generated through licensing the aiOS platform and individual AI applications for clinical workflows including radiology triage, cardiology, neurovascular, and vascular care coordination.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise platform licensing with custom pricing based on health system scope |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Aidoc product offering
Product offeringCore offering
Aidoc develops and sells the aiOS clinical AI operating system and CARE foundation model, an enterprise SaaS platform that deploys FDA-cleared AI applications for radiology triage, cardiology, neurovascular, and vascular care coordination across hospital networks. The platform supports both Aidoc's proprietary AI algorithms and third-party AI models, enabling health systems to operationalize clinical AI at scale with intelligent orchestration, performance monitoring, and care coordination workflows.
Product overview
Aidoc offers a unified clinical AI platform architecture consisting of aiOS (the enterprise operating system) and CARE (the foundation model), with specialized AI solutions across four clinical domains: Radiology (medical imaging analysis and triage), Cardiology (coronary artery disease and echocardiography), Neurovascular (stroke, hemorrhage, brain aneurysm, spine), and Vascular (PE, DVT, aortic diseases, IVC filters). The platform provides end-to-end capabilities including intelligent orchestration, care coordination tools, patient management, and governance/analytics. Aidoc operates a partner ecosystem where 69% of customers run non-Aidoc models on aiOS alongside native solutions. The company has received multiple FDA clearances including the industry's first comprehensive foundation model AI for abdomen CT triage covering 14 acute indications.
Differentiator
Problem solved
Functional benefit
Brands
- aiOS: Aidoc's proprietary enterprise AI platform that enables deployment and governance of clinical AI at scale across health systems
- CARE
- aiOS
- aiOS™
Products and services
- aiOS (AI Operating System) Proprietary enterprise AI platform that enables health systems to deploy, orchestrate, and govern clinical AI solutions at scale. Provides intelligent orchestration, real-time performance monitoring, outcome measurement, and PACS/EHR integration for both Aidoc and third-party AI models.
- CARE (Clinical AI Reasoning Engine) Clinical-grade foundation model trained on multimodal data (imaging, clinical notes, lab results) using self-supervised learning. Powers FDA-cleared applications and enables development of new clinical indications up to 20x faster than traditional single-task models.
- Radiology AI Solutions Automated medical imaging analysis to streamline workflows, prioritize findings, activate care teams, and facilitate patient follow-up across emergency, inpatient, and outpatient settings.
- Cardiology AI Solutions Imaging and text-based AI insights for automated coronary artery disease detection and echocardiography analysis to consistently measure disease and capture incidental cardiac findings.
- Neurovascular AI Solutions High-performing algorithms for stroke, hemorrhage, c-spine fracture, and brain aneurysm detection paired with care coordination tools and real-time notification with clinical context from EHR.
- Vascular AI Solutions Workflow streamlining and care coordination for aortic diseases, pulmonary embolism (PE), deep vein thrombosis (DVT), and IVC filter management with centralized patient management.
- Comprehensive Abdomen CT Triage FDA-cleared comprehensive AI triage solution covering 14 acute indications (11 newly cleared + 3 previously cleared) from a single abdomen CT scan, powered by CARE foundation model. Includes aortic dissection, appendicitis, bowel obstructions, and 11 other conditions.
- First Read Investigational AI tool that analyzes chest radiographs and generates preliminary radiology report text for radiologist review. Designed to address radiology interpretation bottlenecks where turnaround times more than doubled between 2014 and 2023.
Quantifiable outcome
- 31% faster time-to-notification for PE patients
- +14 more outcomes
Companies that use Aidoc
Customer profileNamed customers17 records
Segments5 records
Ideal customer profiles3 records
Aidoc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability8 records
Feature5 records
Aidoc partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and strategic.
- NVIDIAcoreStrategic initiative through NVentures for high-performance compute and AI development platforms. Aidoc plans to invest over $150M combining NVIDIA compute with AWS platforms to redefine CARE model performance, efficiency, and real-time inference.
- AWS (Amazon Web Services)coreStrategic cloud partnership for clinical AI platform deployment. Aidoc announced dedicated AWS collaboration as part of foundation model development strategy.
- Advocate HealthstrategicEnterprise-wide rollout announced as part of $150M Series E announcement. One of the largest health system deployments of Aidoc platform.
- European Health Systems (Germany, Netherlands, Sweden)strategicCase studies from Amsterdam, Sweden, and Germany demonstrating AI's real-world impact on triage efficiency. Includes Isala Hospital (Netherlands) first AI-powered PE Response, Asklepios Group Germany 28-hospital deployment, and Stradins Hospital Latvia.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Aidoc competitors and assessment
Company assessmentDirect peers
- Qure.ai: Qure.ai develops deep learning models for radiology, including head CT, chest X-ray, and tuberculosis screening, with multiple FDA clearances. It directly competes with Aidoc in radiology AI triage, though with a broader global health focus including emerging markets.
- Arterys: Arterys (now Tempus) provides cloud-native AI medical imaging platform with FDA-cleared applications for cardiac MR, oncology, and lung CT. It directly competes with Aidoc in AI-powered imaging analysis, though it has expanded its focus to broader AI applications through Tempus.
- HeartFlow: HeartFlow provides AI-driven coronary CT angiography analysis for non-invasive assessment of coronary artery disease, directly competing with Aidoc's cardiology solutions. Both target large health systems and have achieved meaningful commercial traction.
- RapidAI: RapidAI provides AI solutions for stroke, aneurysm, and PE detection and care coordination, directly competing with Aidoc in neurovascular and vascular AI applications. Both companies target large health systems with imaging-based triage and care coordination workflows.
- Viz.ai: Viz.ai is a direct competitor focused on AI-powered care coordination, particularly in stroke and neurovascular care, with FDA-cleared algorithms for large vessel occlusion detection. Like Aidoc, it targets large health systems with enterprise sales and has raised over $250M, competing head-to-head in the same hospital AI budgets.
Emerging players
- Annalise.ai: Annalise.ai offers comprehensive radiology AI covering 130+ findings on chest X-rays, with growing US health system deployments. It is an emerging competitor to Aidoc in multi-finding radiology triage, with a more focused product line on comprehensive X-ray interpretation.
- Nanox (formerly Zebra Medical Vision): Nanox acquired Zebra Medical Vision and now offers AI imaging analytics for radiology, including bone health, breast cancer, and lung disease. It competes with Aidoc in AI-driven imaging interpretation, though with a different commercial model focused on global screening and population health.
Broad incumbents
- Siemens Healthineers AI-Rad Companion: Siemens Healthineers offers AI-Rad Companion for radiology AI, integrated into its imaging modality and PACS infrastructure. It competes with Aidoc as a broad incumbent leveraging installed imaging equipment and health system contracts to deliver AI capabilities.
- Philips HealthSuite: Philips offers IntelliSpace AI and HealthSuite platform, integrating clinical AI into PACS, imaging, and patient monitoring workflows. As a broad incumbent with deep health system relationships, it competes with Aidoc for enterprise AI budgets and can bundle AI into existing contracts.
- GE HealthCare: GE HealthCare is a broad incumbent offering the Edison platform, integrating AI into imaging modalities, PACS, and enterprise imaging solutions. It competes with Aidoc by bundling clinical AI capabilities into installed imaging and PACS infrastructure, with a far larger installed base and budget relationships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat8 records
Key risks6 records
Key highlights7 records
Customer concentration
Aidoc social profiles
Digital presenceAidoc compliance and trust
Trust signalCompliance8 records
Aidoc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aidoc leadership team
Management profileNumber of profiles
Profiles11 records
Aidoc funding detail
Funding detailFunding overview
Funding rounds12 records
Investors18 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aidoc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aidoc
What does Aidoc do?
Aidoc develops and sells the aiOS clinical AI operating system and CARE foundation model, an enterprise SaaS platform that deploys FDA-cleared AI applications for radiology triage, cardiology, neurovascular, and vascular care coordination across hospital networks. The platform supports both Aidoc's proprietary AI algorithms and third-party AI models, enabling health systems to operationalize clinical AI at scale with intelligent orchestration, performance monitoring, and care coordination workflows.
Is Aidoc a public or private company?
Aidoc is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aidoc founded?
Aidoc was founded in 2016. It employs 251 to 500 people.
Where is Aidoc based?
Aidoc is headquartered in Tel Aviv, Israel, in the Middle East region.
How does Aidoc make money?
One revenue line is on record: clinical AI Platform Subscription.
Who are Aidoc's main competitors?
Direct peers on record are Qure.ai, Arterys, HeartFlow, RapidAI and Viz.ai. Emerging players are Annalise.ai and Nanox (formerly Zebra Medical Vision). Broad incumbents are Siemens Healthineers AI-Rad Companion, Philips HealthSuite and GE HealthCare.
Does Aidoc have an API?
No public API is recorded for Aidoc.
What industry is Aidoc in?
Aidoc's product category is Clinical AI Software for Healthcare Imaging. Its primary akta.pro industry code is HDAEANAI, AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI), with a secondary code of HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs). Its NAICS code is 54151 and its SIC code is 7372.